Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms.

BACKGROUND & AIMS The molecular basis underlying visceral hypersensitivity in functional irritable bowel syndrome remains elusive, resulting in poor treatment effectiveness. Because alterations in spinal non-neuronal (astrocytic) glutamate reuptake are suspected to participate in chronic pain, we asked whether such processes occur in visceral hypersensitivity. METHODS Visceral hypersensitivity was induced in Sprague-Dawley rats by maternal separation. Separated adults were given a systemic administration of riluzole (5 mg/kg), an approved neuroprotective agent activating glutamate reuptake. Visceral hypersensitivity was assessed using colorectal distension (40 mm Hg). Somatic nociception was quantified using Hot Plate, Randall-Sellito, and Hargreaves tests. Spinal proteins were quantified using immunofluorescence and Western blot. The dependence of visceral sensory function upon spinal glutamate transport was evaluated by intrathecal injection of glutamate transport antagonist DL-threo-beta-benzyloxyaspartate (TBOA). For in vitro testing of riluzole and TBOA, primary cultures of astrocytes were used. RESULTS We show that riluzole counteracts stress-induced visceral hypersensitivity without affecting visceral response in nonseparated rats or altering nociceptive responses to somatic pain stimulation. In addition, maternal separation produces a reduction in glial excitatory amino acid transporter (EAAT)-1 with no change in EAAT-2 or gamma-amino butyric acid transporters. Stress was not associated with changes in glial fibrillary acidic protein or astrocytic morphology per se. Furthermore, visceral normosensitivity relies on spinal EAAT, as intrathecal TBOA is sufficient to induce hypersensitivity in normal rats. CONCLUSIONS We identify spinal EAAT as a therapeutic target, and establish riluzole as a candidate to counteract gastrointestinal hypersensitivity in disorders such as irritable bowel syndrome.

[1]  T. Dinan,et al.  Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: Differential effects of acute psychological and physical stressors , 2010, Peptides.

[2]  T. Dinan,et al.  Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.

[3]  J. Cryan,et al.  A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? , 2009, Gut.

[4]  C. Svensson,et al.  Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. , 2009, Gastroenterology.

[5]  D. O'Malley,et al.  Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression , 2009, Neuroscience.

[6]  A. Tort,et al.  The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: Reversal by guanosine , 2009, Pharmacology Biochemistry and Behavior.

[7]  P. Scully,et al.  Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.

[8]  Yuan-Fong Lin,et al.  Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[9]  L. Watkins,et al.  Pathological and protective roles of glia in chronic pain , 2009, Nature Reviews Neuroscience.

[10]  H. Manji,et al.  Riluzole in psychiatry: a systematic review of the literature , 2008, Expert opinion on drug metabolism & toxicology.

[11]  J. Rothstein,et al.  Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection , 2008, Neuroscience.

[12]  M. Gobbi,et al.  Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. , 2008, European journal of pharmacology.

[13]  A. Kawamoto,et al.  Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats , 2008, Molecular pain.

[14]  J. Krystal,et al.  Riluzole in the Treatment of Mood and Anxiety Disorders , 2008, CNS drugs.

[15]  E. Mayer,et al.  Novel therapeutic approaches in IBS. , 2007, Current opinion in pharmacology.

[16]  Sébastien Tilleux,et al.  Neuroinflammation and regulation of glial glutamate uptake in neurological disorders , 2007, Journal of neuroscience research.

[17]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[18]  E. López-Bayghen,et al.  Glutamate‐dependent transcriptional regulation of GLAST/EAAT1: a role for YY1 , 2007, Journal of neurochemistry.

[19]  B. Hong,et al.  Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. , 2007, World journal of gastroenterology.

[20]  T. Coderre,et al.  A comparison of the glutamate release inhibition and anti‐allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain , 2007, Journal of neurochemistry.

[21]  H. Weng,et al.  Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation , 2006, Neuroscience.

[22]  D. Price,et al.  Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. , 2006, The journal of pain : official journal of the American Pain Society.

[23]  P. Scully,et al.  Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? , 2006, Gastroenterology.

[24]  P. Dougherty,et al.  Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia , 2005, Neuroscience Letters.

[25]  R. Johns,et al.  Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord , 2005, Pain.

[26]  Stephen B. McMahon,et al.  Immune and glial cell factors as pain mediators and modulators , 2005, Experimental Neurology.

[27]  J. Gu,et al.  Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states , 2005, Molecular pain.

[28]  J. Mao,et al.  Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.

[29]  J. Mao,et al.  Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity , 2022 .

[30]  G. Blackburn-Munro,et al.  A comparison of the anti-nociceptive effects of voltage-activated Na+ channel blockers in the formalin test. , 2002, European journal of pharmacology.

[31]  P. Plotsky,et al.  Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[32]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[33]  M. Rowbotham,et al.  Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions , 2000, Neurology.

[34]  J. Springer,et al.  Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes , 2000, Brain Research.

[35]  P. Mantyh,et al.  Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons , 2000, Neuroscience.

[36]  H. Kehlet,et al.  Effect of riluzole on acute pain and hyperalgesia in humans. , 1999, British journal of anaesthesia.

[37]  J. Wokke.  Riluzole , 1996, The Lancet.

[38]  M. Kavanaugh,et al.  Differential Modulation of Human Glutamate Transporter Subtypes by Arachidonic Acid (*) , 1995, The Journal of Biological Chemistry.

[39]  J. Glowinski,et al.  Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission. , 1992, Anesthesiology.

[40]  D. Drossman,et al.  Recollection of childhood events in adults with irritable bowel syndrome. , 1987, Journal of clinical gastroenterology.